Financial results - BIOSALUS FARMACIE SRL

Financial Summary - Biosalus Farmacie Srl
Unique identification code: 18485855
Registration number: J40/9731/2023
Nace: 4791
Sales - Ron
345.842
Net Profit - Ron
-31.513
Employees
2
Open Account
Company Biosalus Farmacie Srl with Fiscal Code 18485855 recorded a turnover of 2024 of 345.842, with a net profit of -31.513 and having an average number of employees of 2. The company operates in the field of CAEN Ver.3: Intermedieri în comerţul cu amănuntul nespecializat; CAEN Ver.2: Comert cu amanuntul prin intermediul caselor de comenzi sau prin Internet; having the NACE code 4791.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biosalus Farmacie Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 50.410 208.872 290.399 185 0 0 0 0 173.883 345.842
Total Income - EUR 50.410 208.872 333.225 185 0 0 0 0 177.779 345.883
Total Expenses - EUR 59.831 238.930 324.797 1.912 1.948 1.024 1.002 593 181.230 377.395
Gross Profit/Loss - EUR -9.421 -30.058 8.428 -1.727 -1.948 -1.024 -1.002 -593 -3.451 -31.513
Net Profit/Loss - EUR -10.933 -32.156 5.592 -1.732 -1.948 -1.024 -1.002 -593 -3.451 -31.513
Employees 3 4 3 0 0 0 0 0 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 100.0%, from 173.883 euro in the year 2023, to 345.842 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biosalus Farmacie Srl

Rating financiar

Financial Rating -
BIOSALUS FARMACIE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biosalus Farmacie Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biosalus Farmacie Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biosalus Farmacie Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biosalus Farmacie Srl - CUI 18485855

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 77.840 68.564 17.353 15.970 14.617 13.315 12.018 11.462 10.961 0
Current Assets 76.478 132.623 131.585 90.932 88.814 82.291 80.467 80.716 126.440 89.637
Inventories 19.364 53.382 27.136 2.899 3.031 2.973 2.907 2.916 69.123 57.457
Receivables 56.765 76.615 51.537 86.916 84.688 78.244 76.508 76.746 53.476 24.065
Cash 348 2.625 52.912 1.117 1.095 1.075 1.051 1.054 3.840 8.114
Shareholders Funds -35.939 -67.728 -60.991 -61.603 -62.358 -62.200 -61.822 -62.607 -65.776 -107.642
Social Capital 152 151 148 145 142 140 137 137 137 136
Debts 190.410 268.915 209.929 168.505 165.788 157.807 154.307 154.786 203.177 197.279
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4791 - 4791"
CAEN Financial Year 4791
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 89.637 euro in 2024 which includes Inventories of 57.457 euro, Receivables of 24.065 euro and cash availability of 8.114 euro.
The company's Equity was valued at -107.642 euro, while total Liabilities amounted to 197.279 euro. Equity decreased by -42.234 euro, from -65.776 euro in 2023, to -107.642 in 2024.

Risk Reports Prices

Reviews - Biosalus Farmacie Srl

Comments - Biosalus Farmacie Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.